Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Alife Health
Alife Health, Inc.Alife Health Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Alife Health match what happens in practice?
Public evidence
Alife Health raises $22M series A for fertility AI tools - Fierce Healthcare
Fierce Healthcare
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 1 public external signal(s) across 1 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Alife Health through regulatory records, company records and external market activity.
- Category
- womens-health
What HealthAratus is still learning
HealthAratus is beginning to understand Alife Health. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Alife Health is a platform that uses computational analysis of embryo images. It helps clinicians during the embryo selection process for IVF.According to Alife Health, Inc.
What Alife Health, Inc. states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The platform provides computational analysis of embryo imagery to assist with selection.
According to Alife Health, Inc.
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported outcome
Alife Health raises $22M series A for fertility AI tools - Fierce Healthcare
According to Fierce Healthcare
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Alife Health is a platform that leverages computational analysis of embryo imagery to assist clinicians in the embryo selection process during in vitro fertilization (IVF).
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in lab settings, United States
Key strength
Regulatory: FDA 510(k) clearance
Key capabilities
Embryo image analysis, Clinical decision support for embryologists, Automated embryo grading
Clinical use cases
Assisted reproductive technology (ART) optimization, In vitro fertilization (IVF) embryo selection, Reduction of time to pregnancy
Who uses it
Embryologists, Fertility clinicians, IVF laboratory directors
Parent Company
Alife Health, Inc.vendor
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Alife Health accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence